表紙
市場調査レポート

Mirna Therapeutics, Inc.:製品パイプライン分析

Mirna Therapeutics, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 199741
出版日 ページ情報 英文 34 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
Mirna Therapeutics, Inc.:製品パイプライン分析 Mirna Therapeutics, Inc. - Product Pipeline Review - 2015
出版日: 2015年02月28日 ページ情報: 英文 34 Pages
概要

Mirna Therapeutics, Inc.は、miRNAを使用した癌治療製品を研究・開発するバイオ医薬品企業です。

当レポートでは、Mirna Therapeutics, Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Mirna Therapeutics, Inc.の基本情報

Mirna Therapeutics, Inc.の概要

  • 主要情報
  • 企業情報

Mirna Therapeutics, Inc.:R&Dの概要

  • 主な治療範囲

Mirna Therapeutics, Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Mirna Therapeutics, Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Mirna Therapeutics, Inc.:薬剤プロファイル

  • MRX-34
  • Mir-Rx01
  • miR-Rx02
  • MiR-Rx03
  • MiR-Rx06
  • MiR-Rx07
  • mIR-Rx16
  • MiR-Rxlet-7

Mirna Therapeutics, Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別

Mirna Therapeutics, Inc.:最近のパイプライン動向

Mirna Therapeutics, Inc.:休止中のプロジェクト

Mirna Therapeutics, Inc.:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC06840CDB

Summary

Global Markets Direct's, 'Mirna Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Mirna Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Mirna Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Mirna Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Mirna Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Mirna Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Mirna Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Mirna Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Mirna Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Mirna Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Mirna Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Mirna Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Mirna Therapeutics, Inc. Snapshot
    • Mirna Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Mirna Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Mirna Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Mirna Therapeutics, Inc. - Pipeline Products Glance
    • Mirna Therapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Mirna Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Mirna Therapeutics, Inc. - Drug Profiles
    • MRX-34
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • let-7 + miR-34
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • miR-Rx06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • miR-Rx07
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • mIR-Rx16
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • miR-Rxlet-7
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Mirna Therapeutics, Inc. - Pipeline Analysis
    • Mirna Therapeutics, Inc. - Pipeline Products by Target
    • Mirna Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Mirna Therapeutics, Inc. - Pipeline Products by Molecule Type
  • Mirna Therapeutics, Inc. - Recent Pipeline Updates
  • Mirna Therapeutics, Inc. - Dormant Projects
  • Mirna Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Mirna Therapeutics, Inc., Key Information
  • Mirna Therapeutics, Inc., Key Facts
  • Mirna Therapeutics, Inc. - Pipeline by Indication, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Mirna Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Mirna Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Mirna Therapeutics, Inc. - Partnered Products in Pipeline, 2015
  • Mirna Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Mirna Therapeutics, Inc. - Phase I, 2015
  • Mirna Therapeutics, Inc. - Preclinical, 2015
  • Mirna Therapeutics, Inc. - Discovery, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Target, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Mirna Therapeutics, Inc. - Recent Pipeline Updates, 2015
  • Mirna Therapeutics, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Mirna Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Mirna Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Mirna Therapeutics, Inc. - Partnered Products in Pipeline, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Mirna Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top